US Stock MarketDetailed Quotes

MRK Merck & Co

Watchlist
  • 90.580
  • +1.200+1.34%
Close Feb 27 16:00 ET
  • 90.200
  • -0.380-0.42%
Post 19:27 ET
228.81BMarket Cap13.44P/E (TTM)

About Merck & Co Company

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Company Profile

SymbolMRK
Company NameMerck & Co
Listing DateMay 15, 1946
Founded1891
CEOMr. Robert M. Davis
MarketNYSE
Employees75000
Fiscal Year Ends12-31
Address126 East Lincoln Avenue
CityRahway
ProvinceNew Jersey
CountryUnited States of America
Zip Code07065
Phone1-908-740-4000

Company Executives

  • Name
  • Position
  • Salary
  • Robert M. Davis
  • Chairman of the Board, President and Chief Executive Officer
  • 20.27M
  • Chirfi Guindo
  • Senior Vice President, Human Health and Chief Marketing Officer
  • --
  • Betty D. Larson
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Cristal N. Downing
  • Executive Vice President and Chief Communications and Public Affairs Officer
  • --
  • Caroline A. Litchfield
  • Executive Vice President and Chief Financial Officer
  • 8.30M
  • Michael A Klobuchar
  • Executive Vice President and Chief Strategy Officer
  • --
  • David Michael Williams
  • Executive Vice President and Chief Information and Digital Officer
  • --
  • Dalton E. Smart, III
  • Senior Vice President, Finance, Global Controller and Principal Accounting Officer
  • --
  • Joseph Romanelli
  • Senior Vice President and President, MSD, International Human Health
  • --
  • Richard R. DeLuca, Jr
  • Executive Vice President and President, Merck Animal Health
  • 6.20M
  • Jennifer Zachary
  • Executive Vice President and General Counsel
  • --
  • Dean Y. Li
  • Executive Vice President and President, Merck Research Laboratories
  • 9.78M
  • Sanat Chattopadhyay
  • Executive Vice President and President, Merck Manufacturing
  • 6.24M
  • Jannie Oosthuizen
  • Senior Vice President and President, Merck U.S. Human Health
  • --
  • Surendralal L. Karsanbhai
  • Director
  • --
  • Kathy J. Warden
  • Independent Director
  • 350.00K
  • Dr. Risa J. Lavizzo-Mourey,M.D.
  • Independent Director
  • 365.00K
  • Inge G. Thulin
  • Independent Director
  • 340.00K
  • Douglas M. Baker, Jr
  • Independent Director
  • 347.64K
  • Mary Ellen Coe
  • Independent Director
  • 342.36K
  • Patricia F. Russo
  • Independent Director
  • 360.00K
  • Dr. Paul B. Rothman, M.D.
  • Independent Director
  • 380.00K
  • Pamela J. Craig
  • Independent Director
  • 400.00K
  • Dr. Stephen L. Mayo, PhD
  • Independent Director
  • 350.00K
  • Thomas Henry Glocer
  • Lead Independent Director
  • 430.10K
  • Dr. Christine E. Seidman, M.D.
  • Independent Director
  • 350.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More